Ultragenyx
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $147,026 | $108,833 | $127,392 | $98,052 |
Gross Profit | 116,884 | 82,455 | 115,341 | 87,065 |
EBITDA | -107,499 | -156,502 | -103,235 | -139,915 |
EBIT | -116,361 | -165,347 | -111,453 | -147,106 |
Net Income | -131,598 | -170,684 | -123,190 | -159,649 |
Net Change In Cash | 147,026 | 108,833 | 127,392 | 98,052 |
Free Cash Flow | -81,472 | -203,938 | -85,504 | -121,569 |
Cash | 486,865 | 118,554 | 213,584 | 72,575 |
Basic Shares | 86,580 | 84,286 | 81,118 | 71,664 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $434,249 | $363,329 | $351,406 | $271,030 |
Gross Profit | 389,040 | 335,009 | 335,398 | 264,901 |
EBITDA | -516,851 | -639,411 | -381,496 | -322,471 |
EBIT | -542,857 | -657,611 | -394,735 | -334,732 |
Net Income | -606,639 | -707,421 | -454,025 | -186,566 |
Net Change In Cash | 434,249 | 363,329 | 351,406 | 271,030 |
Cost of Revenue | -170,909 | -415,515 | 288,931 | |
Free Cash Flow | -521,573 | -526,588 | -411,788 | -176,125 |
Cash | 213,584 | 132,944 | 307,584 | 713,526 |
Basic Shares | 73,543 | 69,914 | 67,795 | 60,845 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$1.52 |
2024-03-31 | -$2.03 |
2023-12-31 | -$1.52 |
2023-09-30 | -$2.23 |
